Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

被引：3

作者：

Alexander, Thomas ^{[1
]}

Lacayo, Norman J. ^{[2
]}

Pullarkat, Vinod A. ^{[3
]}

Jabbour, Elias J. ^{[4
]}

Khaw, Seong Lin ^{[5
]}

Mullighan, Charles G. ^{[6
,7
]}

Bajel, Ashish ^{[8
]}

Leonard, Jessica ^{[9
]}

Norris, Robin ^{[10
]}

Rubnitz, Jeffrey ^{[11
]}

Vear, Susan I. ^{[12
]}

Schmidt, Michelle ^{[13
]}

Tong, Bo ^{[13
]}

Zhou, Ying ^{[13
]}

Ross, Jeremy A. ^{[13
]}

Rosenwinkel, Lindsey ^{[13
]}

Jacobson, Amanda ^{[13
]}

Kim, Su Young ^{[13
]}

Stock, Wendy ^{[14
]}

机构：

[1] Univ N Carolina, Dept Pediat, Chapel Hill, NC USA

[2] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA

[3] City Hope Natl Med Ctr, Dept Hematol HCT, 1500 E Duarte Rd, Duarte, CA 91010 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[5] Royal Childrens Hosp, Melbourne, Vic, Australia

[6] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN USA

[7] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA

[8] Royal Melbourne Hosp, Melbourne, Vic, Australia

[9] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA

[10] Cincinnati Childrens Hosp Med Ctr, Canc & Blood Dis Inst, Cincinnati, OH 45229 USA

[11] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

[12] Nationwide Childrens Hosp, Pediat Hematol & Oncol, Columbus, OH USA

[13] AbbVie Inc, N Chicago, IL USA

[14] Univ Chicago, Dept Med, Sect Hematol Oncol, 5841 S Maryland Ave, Chicago, IL 60637 USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-113464

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3966

引用

页数：4

共 50 条

[41] Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia
Shimony, Shai
Liu, Yiwen
Valtis, Yannis K.
Paolino, Jonathan D.
Place, Andrew E.
Brunner, Andrew M.
Weeks, Lachelle D.
Silverman, Lewis B.
Vrooman, Lynda M.
Neuberg, Donna S.
Stone, Richard M.
DeAngelo, Daniel J.
Luskin, Marlise R.
BLOOD ADVANCES, 2023, 7 (07) : 1092 - 1102
[42] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
Jeha, S
Gaynon, PS
Razzouk, BI
Franklin, J
Kadota, R
Shen, V
Litchtman-Jones, L
Rytting, M
Bomgaars, LR
Rheingold, S
Ritchey, K
Albano, E
Arceci, RJ
Goldman, S
Griffin, T
Altman, A
Gordon, B
Steinherz, L
Weitman, S
Steinherz, P
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (12) : 1917 - 1923
[43] Dose Optimization of Inotuzumab Ozogamicin in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Deangelo, Daniel J.
Chen, Ying
Cassaday, Ryan D.
Hibma, Jennifer
Yang, Derek Z.
Garrett, May
Zhang, Fan
Dimitrov, Svetoslav H.
Vandendries, Erik
Kantarjian, Hagop M.
BLOOD, 2024, 144 : 732 - 733
[44] CLOFARABINE FOLLOWED BY CYCLOPHOSPHAMIDE FOR TREATMENT OF RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS
Malato, A.
Santoro, A.
Felice, R.
Turri, D.
Magrin, S.
Di Bella, R.
Scime, R.
Salemi, D.
Acquaviva, F.
Fabbiano, F.
HAEMATOLOGICA, 2012, 97 : 490 - 490
[45] A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
Al-Kali, Aref
Aldoss, Ibrahim
Atherton, Pamela J.
Strand, Carrie A.
Shah, Bijal
Webster, Jonathan
Bhatnagar, Bhavana
Flatten, Karen S.
Peterson, Kevin L.
Schneider, Paula A.
Buhrow, Sarah A.
Kong, Jianping
Reid, Joel M.
Adjei, Alex A.
Kaufmann, Scott H.
CANCER MEDICINE, 2023, 12 (23): : 21229 - 21239
[46] Current therapy and novel agents for relapsed or refractory acute lymphoblastic leukemia
Dinner, Shira
Lee, Daniel
Liedtke, Michaela
LEUKEMIA & LYMPHOMA, 2014, 55 (08) : 1715 - 1724
[47] Daratumumab for relapsed/refractory Philadelphia-positive acute lymphoblastic leukemia
Ganzel, Chezi
Kharit, Mira
Duksin, Chen
Rowe, Jacob M.
HAEMATOLOGICA, 2018, 103 (10) : E489 - E490
[48] Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemia
George, Binsah
Kantarjian, Hagop
Jabbour, Elias
Jain, Nitin
IMMUNOTHERAPY, 2016, 8 (02) : 135 - 143
[49] Bortezomib Combined Chemotherapy for Children with Relapsed/refractory Acute Lymphoblastic Leukemia
Sakaguchi, Hirotoshi
Maemura, Ryo
Yamamori, Ayako
Wakamatsu, Manabu
Yoshida, Nao
Kato, Koji
PEDIATRIC BLOOD & CANCER, 2017, 64 : S89 - S90
[50] Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomibbased chemotherapy
Zhao, Junmei
Wang, Chao
Song, Yongping
Liu, Yuzhang
Fang, Baijun
INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2015, 8 : 211 - 214

← 1 2 3 4 5 →